What was the market valuation of the US stem cell-therapy market in 2024?

The market valuation was $22.75 Million in 2024. Read More

What is the projected market valuation for the US stem cell-therapy market in 2035?

The projected valuation for 2035 is $95.5 Million. Read More

What is the expected CAGR for the US stem cell-therapy market during the forecast period 2025 - 2035?

The expected CAGR is 13.93% during the forecast period 2025 - 2035. Read More

What were the valuations for Cell Therapy and Tissue Engineering in 2024?

Cell Therapy was valued at $5.5 Million, while Tissue Engineering was valued at $4.5 Million in 2024. Read More

What is the valuation range for Adult Stem Cells in the US stem cell-therapy market?

The valuation range for Adult Stem Cells is $8.5 Million to $35.0 Million. Read More

Who are the key players in the US stem cell-therapy market?

Key players include Novartis, Roche, Mesoblast, Athersys, Cellerant Therapeutics, Osiris Therapeutics, StemCells Inc., and Kite Pharma. Read More

What sources of stem cells are utilized in the US stem cell-therapy market?

Sources include Bone Marrow, Cord Blood, Adipose Tissue, and Peripheral Blood. Read More

What were the valuations for hospitals and research institutions in the US stem cell-therapy market in 2024?

Hospitals were valued at $5.5 Million, and research institutions were valued at $6.0 Million in 2024. Read More

US Stem Cell Therapy Market

Q: Which application segments are included in the US stem cell-therapy market?

The application segments include Cell Therapy, Tissue Engineering, Regenerative Medicine, and Gene Therapy. Read More

Q: What types of stem cells are recognized in the US stem cell-therapy market?

The recognized types of stem cells include Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, and Mesenchymal Stem Cells. Read More

ID: MRFR/HC/16489-CR

100 Pages

Satyendra Maurya

Last Updated: January 29, 2026

US Stem Cell Therapy Market Research Report: Size, Share, Trend Analysis By End Users (Hospitals, Research Institutions, Pharmaceutical Companies, Biotechnology Companies) By Applications (Cell Therapy, Tissue Engineering, Regenerative Medicine, Gene Therapy) By Types of Stem Cells (Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells) By Source of Stem Cells (Bone Marrow, Cord Blood, Adipose Tissue, Peripheral Blood) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Application (USD Million)
  1. 4.1.1 Cell Therapy
  2. 4.1.2 Tissue Engineering
  3. 4.1.3 Regenerative Medicine
  4. 4.1.4 Gene Therapy
2. 4.2 Food, Beverages & Nutrition, BY Type of Stem Cells (USD Million)
  1. 4.2.1 Embryonic Stem Cells
  2. 4.2.2 Adult Stem Cells
  3. 4.2.3 Induced Pluripotent Stem Cells
  4. 4.2.4 Mesenchymal Stem Cells
3. 4.3 Food, Beverages & Nutrition, BY Source of Stem Cells (USD Million)
  1. 4.3.1 Bone Marrow
  2. 4.3.2 Cord Blood
  3. 4.3.3 Adipose Tissue
  4. 4.3.4 Peripheral Blood
4. 4.4 Food, Beverages & Nutrition, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Research Institutions
  3. 4.4.3 Pharmaceutical Companies
  4. 4.4.4 Biotechnology Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Novartis (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Mesoblast (AU)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Athersys (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cellerant Therapeutics (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Osiris Therapeutics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 StemCells Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Kite Pharma (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY TYPE OF STEM CELLS
4. 6.4 US MARKET ANALYSIS BY SOURCE OF STEM CELLS
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY TYPE OF STEM CELLS, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY TYPE OF STEM CELLS, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY SOURCE OF STEM CELLS, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY SOURCE OF STEM CELLS, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE OF STEM CELLS, 2025-2035 (USD Million)
  3. 7.2.3 BY SOURCE OF STEM CELLS, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Application (USD Million, 2025-2035)

Cell Therapy
Tissue Engineering
Regenerative Medicine
Gene Therapy

Food, Beverages & Nutrition By Type of Stem Cells (USD Million, 2025-2035)

Embryonic Stem Cells
Adult Stem Cells
Induced Pluripotent Stem Cells
Mesenchymal Stem Cells

Food, Beverages & Nutrition By Source of Stem Cells (USD Million, 2025-2035)

Bone Marrow
Cord Blood
Adipose Tissue
Peripheral Blood

Food, Beverages & Nutrition By End User (USD Million, 2025-2035)

Hospitals
Research Institutions
Pharmaceutical Companies
Biotechnology Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”